Related Experiment Video
Updated: Jan 23, 2026

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Prognostic Significance of Phosphorylated Fyn in Patients with Lung Adenocarcinoma after Lung Resection
Shigeto Nishikawa1, Toshi Menju1, Koji Takahashi1
1Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan.
Purpose:
Src family tyrosine kinases, including Fyn, are non-receptor tyrosine kinases that drive malignancy in various kinds of cancers. Fyn has also been suggested to be an effector of epidermal growth factor receptor (EGFR) signaling, and is recognized as a potential therapeutic target. However, little is known about the clinical importance of phosphorylated Fyn (pFyn) in lung adenocarcinoma. The purpose of this study is to examine the prognostic significance of pFyn in this disease.
Methods:
A total of 282 lung adenocarcinoma specimens were collected from patients who underwent surgery at our institute. A tissue microarray was assembled from paraffin-embedded tumor blocks. pFyn expression was analyzed through immunostaining of the tissue microarray and each case was classified as positive or negative. The association of clinical information with pFyn expression was analyzed statistically.
Results:
pFyn was positive in 107 cases. A pFyn-positive status was significantly associated with male gender, p53 mutant, pathological stage, tumor size, plural invasion, lymphatic invasion, vascular invasion, and differentiation. pFyn positivity was associated with poor relapse-free survival (RFS; hazard ratio [HR]: 2.11, 95% confidence interval [CI]: 1.32-3.42, p <0.01) and poor overall survival (OS; HR: 1.95, 95% CI: 1.17-3.33, p = 0.01).
Conclusion:
pFyn expression may affect the prognosis of patients with lung adenocarcinoma after lung resection.
Insights
Phosphorylated Fyn (pFyn) expression is linked to poorer outcomes in lung adenocarcinoma patients. This finding suggests pFyn may be a prognostic marker for lung cancer survival.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Src family tyrosine kinases, including Fyn, are implicated in cancer progression.
- Fyn is a known effector of epidermal growth factor receptor (EGFR) signaling and a potential therapeutic target.
- The prognostic value of phosphorylated Fyn (pFyn) in lung adenocarcinoma remains largely unexplored.
Purpose of the Study:
- To investigate the prognostic significance of pFyn expression in lung adenocarcinoma.
- To determine the association between pFyn status and patient survival outcomes.
Main Methods:
- Analysis of 282 lung adenocarcinoma specimens using tissue microarrays.
- Immunohistochemical assessment of pFyn expression, classifying cases as positive or negative.
- Statistical analysis correlating pFyn expression with clinical parameters and survival data.
Main Results:
- pFyn expression was detected in 107 out of 282 cases.
- pFyn positivity significantly correlated with male gender, p53 mutations, advanced pathological stage, larger tumor size, and increased invasion (plural, lymphatic, vascular).
- pFyn positivity was associated with significantly poorer relapse-free survival (RFS) and overall survival (OS).
Conclusions:
- Phosphorylated Fyn (pFyn) expression is a significant prognostic indicator in lung adenocarcinoma.
- pFyn may influence patient prognosis following surgical resection for lung adenocarcinoma.
More Related Videos
Related Concept Videos
Lung Capacity
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Pleura of the Lungs
Gross Anatomy of the Lungs
Statistical Significance
Cholesterol: Significance and Regulation
Considering cholesterol and...

